Envista Holdings CorpNVST

Envista Holdings Corp -the dental equipment and consumables outfit that spun out of Danaher in 2019-just published its latest quarterly filing and showed revenue of $705.5 million for the three months ended 3 April 2026, alongside net income of $38.7 million and operating income of $62.5 million. The cash flow story, however, is less flattering: net cash used in operating activities clocked in at negative $3.3 million, while capex gobbled up $12.5 million and inventories climbed $9.6 million.

Envista’s core business is the design, manufacture, and distribution of dental imaging systems, handpieces, CAD/CAM restoratives, and a wide range of consumables sold to dental practices, labs, and DSO networks. The company operates through two reportable segments: Established Products and Growth Products . Established Products covers traditional imaging and handpieces, while Growth Products encompasses orthodontic aligners, implants, and digital workflow solutions. Management frames the split as a balance between steady recurring consumables revenue and higher-margin, higher-growth digital and implant platforms, but the filings do not break out segment-level cash flow, cash conversion, or capital allocation by segment-so investors are left guessing which part of the house is actually funding the next dividend.

Per the 10-Q for the quarter ended 3 April 2026, Envista reported revenue excluding tax of $705.5 million, net income attributable to parent of $38.7 million, operating income of $62.5 million, total assets of $5.58 billion, stockholders’ equity of $3.08 billion, cash and equivalents of $1.08 billion, net cash used in operating activities of $-3.3 million, capex of $12.5 million, R&D expense of $30.0 million, inventories net of $300.3 million, an increase in inventories of $9.6 million, diluted EPS of $0.23, and a diluted weighted average share count of 166.4 million shares. The company also disclosed conflict minerals due diligence in a Form SD dated 28 May 2026, with the Conflict Minerals Report filed as Exhibit 1.01 and posted to the investor site under “Filings & Reports.”

The company’s SEC filings can be browsed via the EDGAR index at https://www.sec.gov/edgar/browse/?CIK=1757073, while the full submissions and company facts datasets are available at https://data.sec.gov/submissions/CIK0001757073.json and https://data.sec.gov/api/xbrl/companyfacts/CIK0001757073.json.

For context on management’s share transactions, four separate Form 4 filings were submitted on 21 May 2026, plus an 8-K filed on 3 June 2026. These documents detail insider sales and holdings but do not disclose the rationale behind the activity, leaving the market to infer whether it’s tax planning, diversification, or simply the dental equivalent of a quarterly teeth-cleaning.